Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Conditions:   Gallbladder Cancer;   Initially Unresectable;   the First Line Treatment Intervention:   Drug: Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab Sponsor:   Lu Wang, MD, PhD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2023 Category: Research Source Type: clinical trials

Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer
Condition:   Gallbladder Cancer Intervention:   Diagnostic Test: CT scan Sponsors:   Postgraduate Institute of Medical Education and Research, Chandigarh;   Radiological Society of North America Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials